REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

MOORE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001448574)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 250,000 Value ($000) $643 Avg Close Range
Q1 2024
Shares 250,000 Value ($000) $1,230 Avg Close Range
Q4 2023
Shares 150,000 Value ($000) $1,319 Avg Close Range
Q3 2023
Shares 160,000 Value ($000) $1,835 Avg Close Range
Q2 2023
Shares 55,000 Value ($000) $1,392 Avg Close Range
Q2 2014
Shares 100,000 Value ($000) $3,400 Avg Close Range